Fast Discharge After Acute Myocardial Infarction Discharge MI

Who May Qualify: - Uncomplicated acute myocardial infarction (NSTEMI and STEMI) diagnosed according to the 2023 acute coronary syndrome guidelines of the ESC - Age ≥ 18 years at time of consent - Invasive management strategy and in case of PCI successful intervention of the culprit lesion defined by post-interventional TIMI 3 flow - Ability to understand and willingness to sign and date written willing to sign a consent form Who Should NOT Join This Trial: - Myocardial infarction complicated by cardiac arrest (out-of-hospital cardiac arrest/in-hospital cardiac arrest) - PCI-related complications (coronary perforation, side branch closure, inability to deliver stent/balloon, aortic dissection, allergic reaction grade ≥2, stroke/thromboembolism, access site complications including pseudoaneurysm, arteriovenous fistula, retroperitoneal hemorrhage and arterial dissection/occlusion or emboli) - Malignant arrhythmias including sustained ventricular arrhythmias and persistent bradycardia (\< 50 beats per minute due to sinus node or atrioventricular conduction system abnormalities, second- /third-degree atrioventricular block) after PCI - Ongoing hemodynamic instability (systolic blood pressure \<90 mmHg, elevated lactate concentrations, need for inotropes or vasopressors) - Ongoing respiratory instability defined by Killip class \>I (rales, pulmonary edema) - Ongoing quantitative disorders of consciousness (somnolence, sopor, coma) - Acute kidney injury defined by Kidney Disease Improving Global Outcomes (KDIGO) stages 2 and 3 - Pregnancy - Untreated critical non-culprit lesions requiring revascularization during index hospitalization not allowing fast discharge - Immobility/limited mobility or social circumstances that prevent fast discharge assessed by an interprofessional care team Always talk to your doctor about whether this trial is right for you.